
|Videos|October 20, 2015
Dr. Minesh Mehta Talks About A Newly-Approved Device To Treat Glioblastoma
Minesh Mehta, MBChB, talks about the recently FDA-approved Optune used to treat newly diagnosed glioblastoma. The device utilizes alternating electric fields to inhibit tumor cell growth.
Advertisement
Minesh Mehta, MBChB, medical director, Maryland Proton Treatment Center, talks about Optune, the recently FDA-approved device used to treat newly diagnosed glioblastoma. The system utilizes alternating electric fields to inhibit tumor cell growth.
Mehta says that he hopes the device will become more widespread in the future after more research comes out about its clinical benefit.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
Zipalertinib Combo Meets PFS End Point in First-Line EGFR Exon 20+ NSCLC
3
FDA Grants Breakthrough Device Designation to Blood-Based Lung Cancer Screening
4
Talquetamab Shows Durable Responses in R/R MM at 3-Year Follow-Up
5
































